language_icon
EN
HI

Ajanta Pharma Share price

AJANTPHARM

2928.9

91.90 (-3.04%)
NSE
BSE
Last updated on 29 May, 2026 | 15:49 IST
Today's High

3060.40

Today's Low

2850.00

52 Week Low

2329.90

52 Week High

3314.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Ajanta Pharma Chart

Ajanta Pharma Share Key Metrics

Volume
2.27 L
Market Cap
36592.39 CR
LTQ@LTP
1@2928.90
ATP
2976.47
Var Margin
15.16 %
Circuit Range
2416.7-3624.9
Delivery %
56.28 %
Value
67.66 CR
ASM/GSM
No
Market Lot
1

Summary

Ajanta Pharma share price is ₹2928.9 as of 31 May, 2026. The stock Ajanta Pharma intraday movement has stayed between ₹2850.00 and ₹3060.40, while on a 52-week basis,Ajanta Pharma price 52 week high is ₹3314.90 & its 52 week low is ₹2329.90.
In terms of trading activity, Ajanta Pharma has recorded a volume of 227318 shares, The Ajanta Pharma has a market cap of ₹124935624 CR. The stock’s Average Traded Price (ATP) stands at ₹2976.47, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹2928.90.
Ajanta Pharma operates within a circuit range of ₹2416.70 – ₹3624.90, with a Value of ₹67.66 CR. The Delivery Percentage for the day is 56.28%. Additionally, Ajanta Pharma currently falls under the No framework, and trades with a market lot size of 1.

Ajanta Pharma Fundamentals

View More
P/E Ratio

34.43

P/B Ratio

8.03

Div. Yield

0.96

Sector P/E

69.96

Sector P/B

3.02

Sec. Div. Yield

0.55

Ajanta Pharma Resistance and Support

Pivot 3050.27

Resistance

First Resistance

3090.54

Second Resistance

3160.27

Third Resistance

3200.54

Support

First Support

2980.54

Second Support

2940.27

Third Support

2870.54

Ajanta Pharma Shareholding Pattern

View More
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2026-27
  • 2025-26
  • 2019-20
  • 2018-19
  • 2016-17
Total Promoters
Segment
Percent

Total Promoters

66.25%

Mutual Fund

15.49%

Insurance

2.65%

Foreign Institutional Investors

7.97%

Domestic Institutional Investors

0.46%

Retail

7.19%

Others

-0.01%

Total Promoters
MAR '25
66.26%
JUN '25
66.26%
SEP '25
66.25%
DEC '25
66.25%

Ajanta Pharma Corporate Actions

DateAgenda
2026-05-05Audited Results
2026-01-30Quarterly Results
2025-11-03Quarterly Results & Interim Dividend
2025-07-28Quarterly Results & Others
2025-04-30Audited Results & A.G.M.
2025-01-30Quarterly Results

Ajanta Pharma News

Ajanta Pharma Ltd - 532331 - Participation In Investor Conference

Ajanta Pharma has scheduled two analyst/institutional investor meetings. The first is with ICICI Securities India on May 29, 2026, and the second is with 360 ONE Capital on June 8, 2026, to discuss already published information.
May 19 2026 15:40:13

Ajanta Pharma Q4 net profit rises 18% despite ₹42 crore forex loss; revenue grows 21%

Ajanta Pharma reported robust Q4 FY24 results, with consolidated net profit increasing 66% to ₹203 crore and revenue from operations rising 20% to ₹1,054 crore, despite a ₹42 crore forex loss. The company's board also approved a share buyback of ₹351 crore at ₹2,770 per share, constituting 0.82% of the total paid-up equity share capital.
May 05 2026 23:57:33

Q4 Results LIVE Updates: Hero MotoCorp PAT ₹1,401 Cr, Coforge PAT ₹612 Cr beat estimates

The article provides live updates on Q4 FY26 earnings for numerous companies, with Ajanta Pharma among those scheduled to announce its financial results today, May 5, 2026. Detailed results for other companies such as United Breweries, Aeroflex Industries, and SRF have been released, but specific financial figures for Ajanta Pharma were not yet available in the provided updates.
May 05 2026 20:37:06

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Ajanta Pharma announced the upload of the audio recording of its earnings call, held on May 5, 2026, to its website. This allows investors to access the discussion regarding the company's financial performance.
May 05 2026 17:58:42

Q4 Results Live Updates: L&T earnings miss estimates; Shoppers Stop posts loss

Ajanta Pharma reported robust financial performance for Q4 FY26, with net profit increasing 18% year-on-year to ₹267 crore. The company's revenue also saw a significant rise of 21% to ₹1,422 crore during the same period.
May 05 2026 17:24:42

Ajanta Pharma Q4 net profit rises 18% despite ₹42 crore forex loss; revenue grows 21%

Ajanta Pharma reported its Q4 FY26 results with net profit rising 18% and revenue growing 21%, despite experiencing a ₹42 crore forex loss during the quarter.
May 05 2026 15:57:59

Ajanta Pharma Ltd - 532331 - Board Meeting Outcome for Outcome Of Board Meeting

Ajanta Pharma announced Q4 FY26 consolidated revenue increased 21% to ₹1,422 crore, with net profit up 18% to ₹267 crore. For the full year FY26, consolidated revenue was ₹5,453 crore and net profit reached ₹1,056 crore.
May 05 2026 15:25:54
Read More

Ajanta Pharma Management

NamePosition
Gaurang ShahSr. VP – Legal, Company Secretary & Compliance Officer
Mannalal B AgrawalChairman
View More

Ajanta Pharma FAQs

The Buying Price of Ajanta Pharma share is 2928.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Ajanta Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ajanta Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Ajanta Pharma shares is 34.43. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Ajanta Pharma shares is 8.03. Useful to assess the stock's value relative to its book value.

To assess Ajanta Pharma’s valuation compare Sector P/E, P/B which are 69.96 & 3.02 with sector averages, along with growth rates and financial metrics.

The Market Cap of Ajanta Pharma is 36592.39 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Ajanta Pharma share price is 3314.90 & 2329.90. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Ajanta Pharma belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost